Full Press Release Details
TARRYTOWN, N.Y.,April 29, 2020/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management participation as follows:
• Bank of America Securities Virtual Health Care Conference at8:20 a.m. ET on Tuesday, May 12, 2020
• RBC Capital Markets Virtual Global Healthcare Conference at9:45 a.m. ET on Tuesday, May 19, 2020
• Bernstein's 36thAnnual Strategic Decisions Conference at10:00 a.m. ET on Wednesday, May 27, 2020
The sessions may be accessed from the "Investors & Media" page of Regeneron's website athttp://investor.regeneron.com/events-and-presentations. Replays of the webcasts will be archived on the Company's website for at least 30 days.
About RegeneronRegeneron (NASDAQ:REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietaryVelociSuite®technologies, such asVelocImmune®, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visitwww.regeneron.comor follow @Regeneron on Twitter.